SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor

Clinical trial NCT06350006 · RECRUITING

Trial details

NCT number: NCT06350006
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CLDN18.2-positive Advanced Solid Tumor

Start date: 2024-05-29
Primary completion: 2027-12-30
Enrollment: 924

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.